Table 3.

Haematuria cancer risk score cut‐offs with corresponding sensitivity, specificity, true positive and negative and false positive and negative derived from the ROC curve in the development and validation cohort

Cut‐off	Development cohort						Validation cohort
	TP	FN	FP	TN	Specificity (95% CI)	Sensitivity (95% CI)	TP	FN	FP	TN	Specificity (95% CI)	Sensitivity (95% CI)
3.240	282	3	3058	196	0.060 (0.053, 0.069)	0.993 (0.982, 1.000)	70	0	517	69	0.118 (0.092, 0.143)	1.000 (1.000, 1.000)
3.897	279	6	2748	506	0.156 (0.143, 0.168)	0.979 (0.961, 0.993)	69	1	428	158	0.270 (0.232, 0.306)	0.986 (0.957, 1.000)
4.015	277	8	2656	598	0.184 (0.170, 0.198)	0.972 (0.954, 0.989)	69	1	406	180	0.305 (0.268, 0.346)	0.986 (0.957, 1.000)
4.334	274	11	2380	874	0.269 (0.254, 0.284)	0.961 (0.937, 0.982)	67	3	336	250	0.425 (0.386, 0.468)	0.957 (0.914, 1.000)
4.386	271	14	2337	917	0.282 (0.267, 0.298)	0.951 (0.923, 0.975)	66	4	324	262	0.445 (0.406, 0.486)	0.943 (0.886, 0.986)
4.492	268	17	2239	1015	0.312 (0.296, 0.329)	0.940 (0.912, 0.965)	65	5	296	290	0.494 (0.454, 0.536)	0.929 (0.871, 0.986)
4.559	265	20	2171	1083	0.333 (0.317, 0.349)	0.930 (0.898, 0.958)	65	5	285	301	0.512 (0.473, 0.556)	0.929 (0.871, 0.986)
4.681	263	22	2050	1204	0.370 (0.354, 0.387)	0.923 (0.891, 0.951)	65	5	261	325	0.555 (0.514, 0.596)	0.929 (0.871, 0.986)
4.681	262	23	2050	1204	0.370 (0.354, 0.387)	0.919 (0.888, 0.951)	65	5	261	325	0.555 (0.514, 0.596)	0.929 (0.871, 0.986)
4.916	256	29	1806	1448	0.445 (0.428, 0.462)	0.898 (0.863, 0.930)	60	10	216	370	0.631 (0.592, 0.671)	0.857 (0.771, 0.929)

95% CI, 95% confidence interval; FN, false negative; FP, false positive; TN, true negative; TP, true positive.